Flomerics Group PLC
04 September 2006
Flomerics Group PLC ("Flomerics" or the "Company")
Appointment of Director
Subsequent to the announcement made by the Company on 15 June 2006, regarding
the proposed acquisition of Nika GmbH (Nika) and the Extraordinary General
Meeting held on 5 July 2006, the board is pleased to announce the appointment of
Wolfgang Biedermann, aged 44, as a director of the Company.
Wolfgang Biedermann is CEO of Pricap Venture Partners AG ("Pricap), which prior
to the acquisition by Flomerics, was the largest shareholder in Nika. Pricap is
a venture capital company and has a portfolio of investments with a net equity
value of approximately €35 million. He studied in Paris, Oxford and Berlin at
the EAP, the European School of Management and achieved a BA and achieved an MBA
with distinction from the Harvard Business School.
Wolfgang Biedermann's continuing directorships over the past five years are as
follows:
Steganos GmbH, Frankfurt
GAM GmbH, Hamburg
Lampito Vermogensverwaltungsgesellschaft mbH, Hamburg
MaWoBi Beteiligungs GmbH, Hamburg
Pricap Venture Partners AG, Hamburg
NEWMEX Holding GmbH, Hamburg
Smart Fuel Cell AG, Munich
PACT XPP Technologies AG, Munich
thinXXS Microtechnology AG, Zweibrucken
UMS United Medical Systems International AG, Hamburg
In addition, in his capacity as a venture capital investor, Mr. Biedermann was a
non-executive director of the privately held early stage company Extr@com AG,
Munich, when it went into receivership in December 2003 and of the privately
held early stage company Scorpion Technologies AG, Hamburg, when it went into
receivership in April 2006.
Gary Carter, Chief Executive, commented:
"I am delighted that Wolfgang, who has a wealth of business experience,
especially in the technology arena will be joining our board and assisting us in
our growth plans."
Wolfgang Biedermann commented:
"I am convinced that by acquiring NIKA, Flomerics has set the grounds to emerge
as a real powerhouse in the fast growing CFD/EFD industry."
There are no other matters to be disclosed in relation to Schedule 2, paragraph
G of the AIM rules.
For further information please contact:
Flomerics Group PLC 020 8487 3000
Gary Carter Chief Executive
Chris Ogle Finance Director
Conduit PR 020 7429 6666
Laurence Read / Angus Prentice 07979 955 923
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.